Home › Themes ›

Foreign investment

Palm oil exports hit by contamination

Down to Earth No. 44, February 2000

A crisis in the oil palm industry is making a mockery of predictions that exports of the crop will help haul Indonesia out of its economic woes.

Export orders for Indonesian palm oil products fell sharply when the first shipment of palm oil, contaminated with diesel oil, was rejected by buyers in the Netherlands in October last year.

West Papua: Independence and exploitation

Down to Earth No. 44, February 2000

Companies which have profited from Indonesia's iron-fisted rule in West Papua, may be starting to feel jittery as calls for independence grow more insistent.

On December 1st last year celebrations took place in towns all over West Papua to mark the 38th anniversary of independence, declared when the territory was still under Dutch rule.

Mining briefs

Down to Earth No 44, February 2000

Kalimantan: bauxite and uranium

West Kalimantan is being lined up for more environmental damage and social disruption with a new bauxite mine in the feasibility study stage and a uranium deposit under detailed exploration work.

UNDERMINING THE FORESTS

Down to Earth No 44, February 2000

The need to control transnational mining companies. A Canadian case study.

Mining companies wait and see

Down to Earth No. 44, February 2000

Companies are hinting they may withhold further investment if conditions don't improve.

Mining companies with mines or exploration programmes in Indonesia are claiming that illegal mining and the collapse of law and order is threatening the mining industry there.

Newmont under fire

Down to Earth No. 44, February 2000

It is no coincidence that JATAM's November meeting was held at the northern tip of Sulawesi.

Advance of the biotech giants

Down to Earth No 43, November 1999

Farmers' groups and NGOs supporting them in south-east Asia are concerned that a second Green Revolution is gathering pace, fuelled by advances in genetic engineering. These developments involve close collaboration between international and national research institutions and the private sector – mainly giant biotech companies.